"VITRONECTIN RECEPTOR ANTAGONIST COMPOUNDDS AND THEIR USE IN THE PREPARATION OF RADIOPHARMACEUTICALS"
Application 5124/DELNP/2005 published 2007-09-28, filed 2005-11-08
The present invention is directed to a compound comprising a thiol derivatized targeting moiety. The targeting moiety binds to a receptor which his upregulated during angiogenesis.
Applicant
1)BRISTOL-MYERS SQUIBB PHARMA COMPANY
:DELAWARE OF P.O. BOX 4000, PRINCETON, NEW JERSEY 08543-4000, U.S.A. U.S.A.
Inventor
1)THOMAS D. HARRIS
International Info
Classification: A61K 47/48
Publication Number: WO 2004/100996
Application Date: 2004-05-12
Priority Information
60/469,728 U.S.A. 2003-05-12